Policy / Regulatory

CDE Launches CARE Plan to Streamline Rare Disease Drug Development

Company

Moderna Inc. Announces Cost-Cutting Measures and Pipeline Realignment

CompanyDeals

Sino Biological and BioGeometry Broaden Partnership to Advance AI-Driven Drug Discovery

CompanyDrug

Johnson & Johnson Submits Second NDA for Nipocalimab to Treat Generalized Myasthenia Gravis

CompanyDrug

Keymed Biosciences’ IL-4Rα mAb Stapokibart Receives NMPA Approval for Atopic Dermatitis Treatment

CompanyPolicy / Regulatory

South Korea’s MFDS Aims to Slash Drug Approval Times with New Innovation Plan

CompanyDeals

Alibaba Health Forges Strategic Partnerships with Viatris and Chinese Pharma Companies for Digital Health Expansion

CompanyDeals

Shanghai Bao Pharmaceutical and Subsidiary Secure Commercialization Rights Deal for SJ02 with Organon China

CompanyDeals

ChemPartner Pharmatech Enters Strategic Partnership with Malaysian Entities to Develop Innovative Drugs

CompanyDeals

Nona Biosciences and Umoja Biopharma Join Forces to Develop In Vivo CAR-T Therapies

CompanyDeals

Beijing’s MoleculeMind Secures Series A Funding to Accelerate AI Protein Design Innovations

General/Other

Leadership Shuffle at China’s National Health Commission: Liu Jinfeng Steps in as Deputy Director